Quince and acupressure put to the test against morning sickness
NCT ID NCT07688629
First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time
Summary
This study tests whether eating fresh quince or applying acupressure (a non-invasive pressure technique) can reduce nausea and vomiting in pregnant women with mild to moderate morning sickness. Researchers will also measure effects on quality of life, stress, and self-care. The goal is to find safe, non-drug options for managing common pregnancy symptoms.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- fresh quince
- What this could lead to
- If effective, quince or acupressure could offer safe, drug-free options for managing mild to moderate morning sickness.
- What could go wrong
- This is a small, early-stage trial. Results may not be conclusive, and quince or acupressure may not work for everyone. Dietary changes during pregnancy should be discussed with a doctor.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
246 people
The number who actually took part.
- Started
-
Nov 2025
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 35 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Pregnant women aged 18-35 years * Gestational age between 6 and 14 weeks * Singleton pregnancy * Mild to moderate nausea and vomiting of pregnancy as assessed by the PUQE-24 scale * Nausea and vomiting not requiring hospitalization or pharmacological treatment * No known gastrointestinal disease * Ability to understand study procedures and provide informed consent * Willingness to participate and comply with study procedures Exclusion Criteria: * Severe nausea and vomiting requiring hospitalization * Nausea and vomiting requiring pharmacological treatment * Multiple pregnancy * Threatened miscarriage * Known gastrointestinal disease * Withdrawal of consent at any stage of the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Morning sickness are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Antalya Bilim Üniversitesi
Antalya, Muratpaşa, 00007, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.